Dr. Reddy’s introduces generic Clolar injection
PRINCETON, N.J. — Dr. Reddy’s Laboratories has launched its generic of Genzyme’s Clolar (clofarabine, 1 mg/ml) injection. The drug is indicated as a treatment for patients ages 1 to 21 years with relapsed or refractory lymphoblastic leukemia after two prior regimens.
The product had brand and generic sales of roughly $53 million for the 12 months ended September 2017, according to IQVIA data. The drug will be available in single-dose 20-ml vials.